{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:06:57Z","timestamp":1788307617590,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.diagmicrobio.2016.03.007","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T13:03:42Z","timestamp":1457442222000},"page":"139-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Susceptibility Testing Conditions on the In Vitro Antibacterial Activity of ETX0914"],"prefix":"10.1016","volume":"87","author":[{"given":"Robert A.","family":"Giacobbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Huband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boudewijn L.M.","family":"deJonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0005","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/AAC.45.6.1919-1922.2001","article-title":"In vitro activities of daptomycin against 2789 clinical isolates from 11 North American medical centers","volume":"45","author":"Barry","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0010","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1038\/srep11827","article-title":"Responding to the challenge of untreatable gonorrhea; ETX0914, a first in class agent with a distinct mechanism-of-action against bacterial type II topoisomerases","volume":"5","author":"Basarab","year":"2015","journal-title":"Nat Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0015","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/AAC.49.9.3903-3909.2005","article-title":"Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method","volume":"49","author":"Bradford","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0020","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","article-title":"M07-A9","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0025","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Wayne, PA. Volume 34. Number 1","article-title":"M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0030","first-page":"1","article-title":"In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations","volume":"23","author":"DeVecchi","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0035","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.24.4.568","article-title":"In Vitro Activity of Ciprofloxacin (Bay o 9867)","volume":"24","author":"Fass","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jac\/dkh180","article-title":"Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492","volume":"53","author":"Harnett","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/AAC.04124-14","article-title":"In Vitro Antibacterial Activity of AZD0914, A new spiropyrimidinetrione DNA Gyrase\/Topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-negative, and atypical bacteria","volume":"59","author":"Huband","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0050","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/AAC.03090-14","article-title":"High In vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggest a new effective option for oral treatment of Gonorrhea","volume":"58","author":"Jacobsson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.coph.2010.06.006","article-title":"Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus","volume":"10","author":"Nanni","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0060","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1128\/AAC.49.9.3910-3918.2005","article-title":"Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates","volume":"49","author":"Petersen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.42.1.269-275.2004","article-title":"Effects of inoculum and \u03b2-lactamase activity in AmpC- and extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology","volume":"42","author":"Queenan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0070","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"JID"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0075","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/AAC.00833-10","article-title":"In Vitro Spectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions","volume":"55","author":"Stubbings","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.03.007_bb0080","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1128\/AAC.00629-13","article-title":"Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa","volume":"57","author":"Tomaras","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316300475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316300475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T09:55:19Z","timestamp":1536918919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316300475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0732889316300475"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.03.007","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Susceptibility Testing Conditions on the In Vitro Antibacterial Activity of ETX0914","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}